To complete the picture, we will show how this pleitropic approach can be implemented in preclinical research by using the example of an experimental antidepressant (spadin and its derivatives) based on a sortilin-derived propeptide (PE) that we recently demonstrated to have beneficial potential in diabetes. This evidence concerns the gene SORT1 and diabetes mellitus.